Venture capital firm inks 14,000 sf lease at 230 Park Avenue

Apple Tree Sciences moving from Princeton, N.J. to open first New York office

TRD New York /
Jun.June 11, 2014 02:30 PM

UPDATED, 4:05 p.m., June 11: Venture capital firm Apple Tree Life Sciences has signed on for 14,169 square feet at 230 Park Avenue for the coming ten years.

Monday Properties and Invesco, which own the building, announced the deal today. Apple Tree Life Sciences, which invests in pharmaceuticals, biotech, medtech and health care services, is relocating from Princeton, N.J. to open its first office in New York City. Asking rent for the space was in the low $80s.

Apple Tree Life Sciences was represented by Ethan Silverstein of Cushman & Wakefield. Monday Properties was represented in-house by Jordan Berger, along with  JLL’s Paul Glickman, Frank Doyle, Jonathan Fanuzzi, David Kleiner and Matthew Polhemus.

The space will be built out by Monday Properties and designed by Gensler.

The lease follows an announcement in February that UrbanSpace will occupy 10,000 square feet at 230 Park Avenue[NYO] – Claire Moses


Related Articles

arrow_forward_ios

Invesco buying 80% stake in $760M AvalonBay portfolio

Hello Alfred raises $40M in Series B

Invesco to purchase Live Nation building for $150M-plus

SL Green, Ivanhoe to sell 1745 Broadway offices for $633M

Invesco lands $102M for 80 Broad St.

Monday Properties to double office space, move to Park Avenue Tower

Invesco buys 80 Broad Street in $235M deal

Regus to launch Spaces co-working concept in Manhattan, at the Helmsley Building

arrow_forward_ios